Key facts
- This page summarizes Keith Anthony Jones's Form 4 filing for Humacyte, Inc. (HUMA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 15 Sep 2026, 16:05.
Keith Anthony Jones - 14 Sep 2026 Form 4 Insider Report for Humacyte, Inc. (HUMA)
- Reporting relationship
- Director
- Issuer ticker
- HUMA
- Reported as of
- 14 Sep 2026
- Net transaction value
- +$5,620
- SEC form
- 4
- Accepted by SEC
- 15 Sep 2026, 16:05:04 UTC
- Prior SEC filing
- 21 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Keith A. Jones by Dale A. Sander as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Keith Anthony Jones filed Form 4 for Humacyte, Inc. (HUMA) on 15 Sep 2026.
Change
- Previous filing in this sequence was filed on 21 Aug 2026.
- Current net transaction value: +$5,620.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002026411
Primary reporting owner
Jones Keith Anthony
- Relationship
- Director
- Address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
- Signature
- /s/ Keith A. Jones by Dale A. Sander as Attorney-in-Fact
- Signature date
- 15 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HUMA
transaction
Common Stock
Purchase
- Transaction value
- $5,620
- Shares
- +10,000
- Change %
- +25%
- Price
- $0.5620
- Shares after
- 50,000
- Date
- 14 Sep 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.